Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Joel Latham
Recent news which mentions Joel Latham
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
September 10, 2024
Tickers
IXHL
Tags
Arena Investors
Arena Business Solutions
Market News
From
Benzinga
Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
July 18, 2023
Tickers
FTRE
IXHL
Tags
News
premium
Benzinga
From
Benzinga
Incannex Stock Trading Higher On Entering A Lease For First Psychedelic-Assisted Psychotherapy Clinic
May 05, 2023
Tickers
IXHL
Tags
Clarion Clinics Group
Markets
Joel Latham
From
Benzinga
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
March 03, 2023
Tickers
CTLT
IXHL
Tags
Penny Stocks
premium
News
From
Benzinga
Incannex Healthcare To Acquire APIRx Pharmaceuticals For $93.3M
March 24, 2022
Tickers
IXHL
Tags
Markets
IXHL
acquisition
From
Benzinga
Psychedelics And Virtual Reality Treatment Developed By Monash University, Funded By Incannex
March 03, 2022
Tickers
IXHL
Tags
Benzinga
Murat Yücel
Rebecca Segrave
From
Benzinga
Medicinal Cannabis And Psychedelics Company Incannex Lists American Depositary Shares On Nasdaq
February 28, 2022
Tickers
IXHL
Tags
Joel Latham
Cannabis
Market News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.